Eastman Chemical Company (EMN) Stock Forecast
Data as of Oct 31, 2026Basic Materials · Current price $65.72 (-3.26%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 9, 2026 | Joshua Spector | UBS | $88.00 | +33.9% |
| Feb 18, 2026 | Eric Boyes | Evercore ISI | $75.00 | +14.1% |
| Jan 16, 2026 | Arun Viswanathan | RBC Capital | $70.00 | +6.5% |
| Jan 7, 2025 | Charles Neivert | Piper Sandler | $102.00 | +55.2% |
| Nov 4, 2024 | Aleksey Yefremov | KeyBanc | $121.00 | +84.1% |
| Oct 16, 2024 | Steve Byrne | Bank of America Securities | $119.00 | +81.1% |
| Sep 25, 2024 | Lawrence Alexander | Jefferies | $130.00 | +97.8% |
| Jul 29, 2024 | David Begleiter | Deutsche Bank | $108.00 | +64.3% |
| May 23, 2024 | Joshua Spector | UBS | $128.00 | +94.8% |
| Apr 30, 2024 | Charles Neivert | Piper Sandler | $105.00 | +59.8% |
| Apr 29, 2024 | Lawrence Alexander | Jefferies | $125.00 | +90.2% |
| Apr 19, 2024 | Arun Viswanathan | RBC Capital | $100.00 | +52.2% |
| Mar 26, 2024 | Lawrence Alexander | Jefferies | $102.00 | +55.2% |
| Aug 31, 2023 | Vincent Andrews | Morgan Stanley | $115.00 | +75.0% |
| May 12, 2023 | Ben Isaacson | Scotiabank | $90.00 | +37.0% |
| May 2, 2023 | Kieran de Brun | Mizuho Securities | $84.00 | +27.8% |
| Apr 11, 2023 | Charles Neivert | Piper Sandler | $99.00 | +50.7% |
| Sep 19, 2022 | Mehdi Hosseini | Susquehanna | $108.00 | +64.3% |
| Sep 19, 2022 | Joshua Spector | UBS | $108.00 | +64.3% |
| Sep 13, 2022 | Michael Sison | Wells Fargo | $95.00 | +44.6% |
Top Analysts Covering EMN
EMN vs Sector & Market
| Metric | EMN | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.34 | 2.41 |
| Analyst Count | 15 | 7 | 19 |
| Target Upside | +17.0% | +577.5% | +21.5% |
| P/E Ratio | 18.99 | -9.30 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.01B | $2.13B | $2.38B | 4 |
| 2027-03-31 | $2.16B | $2.29B | $2.56B | 4 |
| 2027-06-30 | $2.28B | $2.41B | $2.70B | 3 |
| 2027-09-30 | $2.27B | $2.41B | $2.70B | 3 |
| 2027-12-31 | $2.05B | $2.18B | $2.44B | 3 |
| 2028-12-31 | $9.55B | $9.57B | $9.59B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.30 | $1.41 | $1.62 | 7 |
| 2027-03-31 | $1.38 | $1.49 | $1.72 | 3 |
| 2027-06-30 | $1.80 | $1.95 | $2.24 | 3 |
| 2027-09-30 | $1.78 | $1.92 | $2.22 | 4 |
| 2027-12-31 | $1.42 | $1.53 | $1.77 | 3 |
| 2028-12-31 | $7.72 | $7.95 | $8.60 | 4 |
Frequently Asked Questions
What is the analyst consensus for EMN?
The consensus among 15 analysts covering Eastman Chemical Company (EMN) is Buy with an average price target of $81.50.
What is the highest price target for EMN?
The highest price target for EMN is $165.00, set by Vincent Andrews at Morgan Stanley on 2022-01-11.
What is the lowest price target for EMN?
The lowest price target for EMN is $70.00, set by Arun Viswanathan at RBC Capital on 2026-01-16.
How many analysts cover EMN?
15 analysts have issued ratings for Eastman Chemical Company in the past 12 months.
Is EMN a buy or sell right now?
Based on 15 analyst ratings, EMN has a consensus rating of Buy (2.33/5) with a +17.0% upside to the consensus target of $81.50.
What are the earnings estimates for EMN?
Analysts estimate EMN will report EPS of $1.41 for the period ending 2026-12-31, with revenue estimated at $2.13B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.